Phenylketonuria (PKU) affects approximately one in 23,930 newborns globally, with higher prevalence in parts of Europe and the Middle East.
This first-of-its-kind transplantation in Qatar highlights Sidra Medicine’s mission to provide advanced and innovative care for children with complex and high-risk diseases.